about
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer.Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.Clinical assessment of patients with advanced non-small-cell lung cancer eligible for second-line chemotherapy: a prognostic score from individual data of nine randomised trials.Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data.Prognosis of CKD patients receiving outpatient nephrology care in Italy.Biomarker analysis of the phase 3 TORCH trial for first line erlotinib versus chemotherapy in advanced non-small cell lung cancer patientsFirst-line chemotherapy with fluorouracil and folinic acid for advanced colorectal cancer in elderly patients: a phase II study.The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care
P50
Q31108477-5333E7F5-118E-4B90-AB00-D37E5AC73F13Q31141377-3278F059-419E-44DF-B426-41D4509D44D7Q33521596-51B1D3EF-8E78-49EC-81A0-9BEC3CC72A8FQ34219342-B5A1F61F-6953-4D49-BC7B-A13291945E8CQ35985791-47544F61-AD45-48E5-BE2E-44A7F9E39807Q41340872-F9B73468-6CED-45EF-AB4E-F69A75E51CCBQ44318064-EB97AA00-ECA0-47D1-A4A0-A9E56EC87CD2Q58946934-ECBE7CA7-EA01-4CF9-90F5-56D574AF6D90
P50
description
researcher ORCID ID = 0000-0002-7939-3104
@en
wetenschapper
@nl
name
Ciro Gallo
@ast
Ciro Gallo
@en
Ciro Gallo
@es
Ciro Gallo
@nl
type
label
Ciro Gallo
@ast
Ciro Gallo
@en
Ciro Gallo
@es
Ciro Gallo
@nl
prefLabel
Ciro Gallo
@ast
Ciro Gallo
@en
Ciro Gallo
@es
Ciro Gallo
@nl
P1153
57190210901
7103169785
P21
P31
P496
0000-0002-7939-3104